Vanguard Personalized Indexing Management LLC Buys 2,062 Shares of Option Care Health, Inc. $OPCH

Vanguard Personalized Indexing Management LLC grew its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 9.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,561 shares of the company’s stock after purchasing an additional 2,062 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Option Care Health were worth $798,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of OPCH. USA Financial Formulas purchased a new stake in shares of Option Care Health in the second quarter worth approximately $26,000. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after buying an additional 836 shares during the period. Brooklyn Investment Group raised its holdings in shares of Option Care Health by 186.6% in the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock worth $42,000 after buying an additional 780 shares during the period. Bessemer Group Inc. raised its holdings in shares of Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock worth $54,000 after buying an additional 599 shares during the period. Finally, Wealthquest Corp purchased a new position in Option Care Health during the 1st quarter worth $66,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Performance

Shares of OPCH opened at $28.38 on Tuesday. The stock has a 50-day moving average of $28.02 and a two-hundred day moving average of $30.21. The stock has a market cap of $4.61 billion, a P/E ratio of 22.70, a P/E/G ratio of 1.69 and a beta of 0.88. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company’s revenue was up 15.4% on a year-over-year basis. During the same quarter last year, the business posted $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling at Option Care Health

In related news, Director Norman L. Wright acquired 3,411 shares of Option Care Health stock in a transaction on Tuesday, September 9th. The stock was acquired at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. This represents a 28.21% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The shares were bought at an average price of $27.15 per share, with a total value of $977,400.00. Following the purchase, the director directly owned 375,390 shares in the company, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 59,411 shares of company stock worth $1,627,576. Insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on OPCH shares. TD Cowen began coverage on Option Care Health in a report on Thursday, October 2nd. They set a “hold” rating and a $30.00 price objective on the stock. JMP Securities increased their target price on Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a research report on Thursday, July 31st. Morgan Stanley began coverage on Option Care Health in a research report on Friday. They set an “overweight” rating and a $35.00 target price on the stock. Cowen began coverage on Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating on the stock. Finally, Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Thursday, July 31st. Nine investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $35.10.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.